Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...
Today, the Honourable Marjorie Michel, Minister of Health, announced permanent controls as of December 19, 2025, for carisoprodol, a sedative drug that has been found in illegal drug markets around ...
ImmunityBio shows strong commercial momentum with ANKTIVA, reporting significant revenue growth and improved net loss in Q3.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback